These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28169010)

  • 1. Escherichia coli bacteraemia papers.
    Oppenheim B
    J Hosp Infect; 2017 Apr; 95(4):363-364. PubMed ID: 28169010
    [No Abstract]   [Full Text] [Related]  

  • 2. Escherichia coli bacteraemia.
    OWEN T; SPAULDING WB
    Can Med Assoc J; 1956 Dec; 75(12):1020-4. PubMed ID: 13374650
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteraemia caused by Escherichia coli in cancer patients at a specialist center in Pakistan.
    Parveen A; Sultan F; Raza A; Zafar W; Nizamuddin S; Mahboob A; Saleem S; Nazeer SH
    J Pak Med Assoc; 2015 Dec; 65(12):1271-6. PubMed ID: 26627506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.
    Abernethy JK; Johnson AP; Guy R; Hinton N; Sheridan EA; Hope RJ
    Clin Microbiol Infect; 2015 Mar; 21(3):251.e1-8. PubMed ID: 25698659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
    Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and bacterial determinants involved in symptomatic urinary tract infection caused by Escherichia coli with and without bacteraemia.
    Venier AG; Talon D; Patry I; Mercier-Girard D; Bertrand X
    Clin Microbiol Infect; 2007 Feb; 13(2):205-208. PubMed ID: 17328736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Escherichia coli bacteraemia preventable?
    Melzer M; Welch C
    Lancet Infect Dis; 2012 Feb; 12(2):103-4. PubMed ID: 22281141
    [No Abstract]   [Full Text] [Related]  

  • 10. Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.
    Surgers L; Bleibtreu A; Burdet C; Clermont O; Laouénan C; Lefort A; Mentré F; Carbonne B; Bingen E; Meynard JL; Denamur E;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1035-41. PubMed ID: 24979689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.
    Van Aken S; Lund N; Ahl J; Odenholt I; Tham J
    Scand J Infect Dis; 2014 Nov; 46(11):753-62. PubMed ID: 25195648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing hospital-onset Escherichia coli bacteraemia: is hydration the solution?
    Francis RV; Boswell TC; Mahida N
    J Hosp Infect; 2019 Dec; 103(4):474-475. PubMed ID: 31260709
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of enterotoxins among Escherichia coli isolates causing bacteraemia.
    Telli M; Guiral E; Martínez JA; Almela M; Bosch J; Vila J; Soto SM
    FEMS Microbiol Lett; 2010 May; 306(2):117-21. PubMed ID: 20529132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.
    Denis B; Lafaurie M; Donay JL; Fontaine JP; Oksenhendler E; Raffoux E; Hennequin C; Allez M; Socie G; Maziers N; Porcher R; Molina JM
    Int J Infect Dis; 2015 Oct; 39():1-6. PubMed ID: 26189774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli bacteraemia: how preventable is it?
    Underwood J; Klein JL; Newsholme W
    J Hosp Infect; 2011 Dec; 79(4):364-5. PubMed ID: 21864936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
    Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
    J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.